SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-014683
Filing Date
2019-07-11
Accepted
2019-07-11 18:01:13
Documents
2
Period of Report
2019-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1657
2 poa_anderson.htm EX-24 4424
  Complete submission text file 0001567619-19-014683.txt   7396
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
ANDERSON ELIZABETH M (Reporting) CIK: 0001758247 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 19951750